What is the official website of Krystal Biotech, Inc. ?

The official website of Krystal Biotech, Inc. is http://www.krystalbio.com/.

What is Krystal Biotech, Inc.'s cybersecurity risk score?

Krystal Biotech, Inc. has an AI-generated cybersecurity risk score of 784 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Krystal Biotech, Inc. experienced?

According to Rankiteo, Krystal Biotech, Inc. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Krystal Biotech, Inc. been affected by any supply chain cyber incidents ?

According to Rankiteo, Krystal Biotech, Inc. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Krystal Biotech, Inc. have SOC 2 Type 1 certification ?

According to Rankiteo, Krystal Biotech, Inc. is not certified under SOC 2 Type 1.

Does Krystal Biotech, Inc. have SOC 2 Type 2 certification ?

According to Rankiteo, Krystal Biotech, Inc. does not hold a SOC 2 Type 2 certification.

Does Krystal Biotech, Inc. comply with GDPR ?

According to Rankiteo, Krystal Biotech, Inc. is not listed as GDPR compliant.

Does Krystal Biotech, Inc. have PCI DSS certification ?

According to Rankiteo, Krystal Biotech, Inc. does not currently maintain PCI DSS compliance.

Does Krystal Biotech, Inc. comply with HIPAA ?

According to Rankiteo, Krystal Biotech, Inc. is not compliant with HIPAA regulations.

Does Krystal Biotech, Inc. have ISO 27001 certification ?

According to Rankiteo,Krystal Biotech, Inc. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Krystal Biotech, Inc. operate in ?

Krystal Biotech, Inc. operates primarily in the Biotechnology industry.

How many employees does Krystal Biotech, Inc. have ?

Krystal Biotech, Inc. employs approximately 273 people worldwide.

Does Krystal Biotech, Inc. own any subsidiaries ?

Krystal Biotech, Inc. presently has no subsidiaries across any sectors.

How many LinkedIn followers does Krystal Biotech, Inc. have ?

Krystal Biotech, Inc.'s official LinkedIn profile has approximately 24,170 followers.

Does Krystal Biotech, Inc. have a Crunchbase profile ?

Yes, Krystal Biotech, Inc. has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/krystal-biotech.

Does Krystal Biotech, Inc. have a LinkedIn profile ?

Yes, Krystal Biotech, Inc. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/krystal-biotech-inc.

How many cybersecurity incidents has Krystal Biotech, Inc. experienced ?

As of September 14, 2026, Rankiteo reports that Krystal Biotech, Inc. has not experienced any cybersecurity incidents.

How many peer or competitor companies does Krystal Biotech, Inc. have ?

Krystal Biotech, Inc. has an estimated 1,078 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

KBI

Boost Score +25 with badge (5 left)

784

/1000

Fair

809

/1000

Good

Krystal Biotech, Inc. Vendor Cyber Rating & Cyber Score

krystalbio.com

cb in

Add Your Compliance Badge

A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs.

KBI

Krystal Biotech, Inc. CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

KBI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for KBI

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Krystal Biotech, Inc. in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Krystal Biotech, Inc. in 2026.

Incident Types KBI vs Biotechnology Industry Avg (This Year)

No incidents recorded for Krystal Biotech, Inc. in 2026.

Incident History - KBI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Krystal Biotech, Inc. Subsidiaries

Parent Company

KBI

Biotechnology

Website: http://www.krystalbio.com/

Company Size: 273

No subsidiary data available for this company.

Loading…

Krystal Biotech, Inc. Similar Companies

Regeneron

regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

Krystal Biotech, Inc. CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 03, 2026 07:00 AM

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?

KRYS' Vyjuvek growth and expanding genetic medicine pipeline boost investor confidence as the company advances toward multi-product growth.

Read Article

September 02, 2026 07:00 AM

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have added about 12% in that time frame,...

Read Article

August 24, 2026 07:00 AM

Krystal Biotech, Inc. (KRYS) Stock Analysis: Discovering a 11% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company, is drawing significant attention from the investment...

Read Article

August 14, 2026 07:00 AM

Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More

Wall Street flipped the script Friday with a wave of surprise upgrades and downgrades hitting names like Wayfair, Roku, and Fox Corporation,...

Read Article

August 14, 2026 07:00 AM

Krystal Bio wins bullish view at RBC Capital Markets (KRYS)

Krystal Biotech (KRYS) stock is granted an Outperform rating with a $400 price target at RBC Capital Markets citing blockbuster sales for...

Read Article

August 10, 2026 07:00 AM

Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run

Krystal Biotech stock has delivered a very large 5 year return while recent valuation checks and the latest share price action suggest the...

Read Article

August 04, 2026 07:00 AM

Krystal Biotech, Inc. Q2 2026 Earnings Call Summary

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1...

Read Article

August 03, 2026 07:00 AM

Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts

Krystal Biotech, Inc. (NASDAQ:KRYS) reported second-quarter 2026 results on Monday that exceeded earnings expectations but fell short of...

Read Article

August 03, 2026 07:00 AM

Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates

Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.7 per share.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-90603

SUMMARY

A vulnerability was identified in Anil-matcha Open-Generative-AI up to 1.0.11/2.0.0. Affected by this issue is some unknown functionality of the file /api/upload-binary of the component S3 Upload. Such manipulation of the argument x-proxy-target-url leads to unrestricted upload. The attack may be launched remotely. The name of the patch is f013270957f75e439eaf97eb2a93decb32a4543e. Applying a patch is advised to resolve this issue.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-90602

SUMMARY

A vulnerability was determined in Anil-matcha Open-Generative-AI up to 1.0.11/2.0.0. Affected by this vulnerability is the function renderHistory of the file ImageStudio.js of the component Studio Components. This manipulation causes cross site scripting. The attack may be initiated remotely. The pull request to fix this issue awaits acceptance.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 3.5)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.1

REFERENCES

CVE-2026-90601

SUMMARY

A vulnerability was found in getzep graphiti up to 0.30.2. Affected is an unknown function of the file server/graph_service/main.py of the component REST API. The manipulation results in improper authentication. The attack can be launched remotely. The pull request to fix this issue awaits acceptance.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-90600

SUMMARY

A vulnerability has been found in itsourcecode Sales and Inventory System 1.0. This impacts an unknown function of the file /pages/inv_edit1.php. The manipulation of the argument ID leads to sql injection. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-15892

SUMMARY

The mcumgr SMP settings-management group handlers settings_mgmt_read(), settings_mgmt_write(), and settings_mgmt_delete() in subsys/mgmt/mcumgr/grp/settings_mgmt/src/settings_mgmt.c allocate a key_name buffer (and, for read, a data buffer) via k_malloc() when CONFIG_MCUMGR_GRP_SETTINGS_BUFFER_TYPE_HEAP is enabled, relying on the end: label to k_free() them. When CONFIG_MCUMGR_GRP_SETTINGS_ACCESS_HOOK is also enabled and the application access hook rejects a request by returning status MGMT_CB_ERROR_RC, the handler executed return ret_rc; directly, bypassing end: and leaking the heap allocation on every rejected request. The settings handlers are reachable over the unauthenticated SMP transport (Bluetooth LE, UART, or UDP, depending on product configuration). The access hook is the mechanism applications use to deny unauthorized settings access, and MGMT_CB_ERROR_RC is a common rejection style, so an attacker who can send settings read/write/delete commands that the hook rejects triggers a heap leak on each attempt. Because the leaked memory is never reclaimed until reboot, a sustained stream of rejected requests monotonically exhausts the kernel heap until k_malloc() fails, denying mcumgr service and impacting any other heap consumer on the device — a denial of service. The impact is availability-only; there is no memory corruption or information disclosure. Only configurations that select the heap buffer type, enable the access hook, and register a hook that returns MGMT_CB_ERROR_RC are affected (the default stack buffer type cannot leak).

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Krystal Biotech, Inc. Vendor Cyber Rating & Cyber Score

KBI A.I CyberSecurity Scoring

Krystal Biotech, Inc. CyberSecurity News & History

KBI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for KBI

Incidents vs Biotechnology Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types KBI vs Biotechnology Industry Avg (This Year)

Incident History - KBI (X = Date, Y = Severity)

Krystal Biotech, Inc. Subsidiaries

Parent Company

KBI

Krystal Biotech, Inc. Similar Companies

Regeneron

Krystal Biotech, Inc. CyberSecurity News

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

Krystal Biotech, Inc. (KRYS) Stock Analysis: Discovering a 11% Potential Upside in Biotech Innovation

Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More

Krystal Bio wins bullish view at RBC Capital Markets (KRYS)

Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run

Krystal Biotech, Inc. Q2 2026 Earnings Call Summary

Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts

Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Krystal Biotech, Inc. CyberSecurity News & History

KBI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for KBI

Incidents vs Biotechnology Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types KBI vs Biotechnology Industry Avg (This Year)

Incident History - KBI (X = Date, Y = Severity)

Krystal Biotech, Inc. Subsidiaries

Parent Company

KBI

Krystal Biotech, Inc. Similar Companies

Regeneron

Krystal Biotech, Inc. CyberSecurity News

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

Krystal Biotech, Inc. (KRYS) Stock Analysis: Discovering a 11% Potential Upside in Biotech Innovation

Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More

Krystal Bio wins bullish view at RBC Capital Markets (KRYS)

Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run

Krystal Biotech, Inc. Q2 2026 Earnings Call Summary

Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts

Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo